亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

湖北遠藥業有限公司孝南分公司  

有機原料,有機中間體,醫藥中間體,醫藥原料

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:顧亞男
  • 電話:027-50756114
  • 郵件:ycmanagers06@ycphar.com
  • 傳真:027-88048077-951
  • QQ:2355327070
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 雙氯芬酸二乙胺 CAS號: 78213-16-8
雙氯芬酸二乙胺 CAS號: 78213-16-8
單價 195.00 / KG對比
銷量 暫無
發貨 湖北武漢市付款后48小時內
庫存 7000KG起訂1KG
品牌 南箭
過期 長期有效
更新 2015-02-27 09:12
 
詳細信息
中文名稱:雙氯芬酸二乙胺
英文名稱: Diclofenac diethylamine
中文別名: 2-(2,6-二氯苯胺)***二乙胺鹽;雙氯芬酸二乙胺;2-((2,6-二氯苯基)氨基)***二乙胺鹽;雙氯芬酸二乙胺鹽
英文別名: 2-[(2,6-dichlorophenyl)amino]-benzeneacetic acid *pd. with n-ethylethanamine (1:1);DICLOFENAC DIETHYLAMINE;n-ethylethanamine 2-[(2,6-dichlorophenyl)amino]benzeneacetate;2-[(2,6-dichlorophenyl)amino]-benzeneacetic acid *pd. with n-ethylethanamine;2-[2-(2,6-dichloroanilino)phenyl]acetic acid
CAS號: 78213-16-8
分子式: C18H22Cl2N2O2
分子量: 369.29
雙氯芬酸二乙胺 性質
外 觀:白色結晶性粉末
含量:99%
熔點:145-148°C
產品用途:肌腱,韌帶,肌肉和關節創傷性炎癥的局部治療,如扭傷、勞損和挫傷。局限性軟組織風濕病,如腱鞘炎、肩手綜合征和滑囊炎。局限性風濕性疾病,如周圍關節和脊柱的骨關節病,關節周圍病變。
包裝規格:25公斤/紙板桶。
©2025 湖北遠藥業有限公司孝南分公司 版權所有   技術支持:化工網   訪問量:23269  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |